Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 299-316 , June 2008

Arginine vasopressin: a promising rescue drug in the treatment of uncontrolled haemorrhagic shock

  • Martin W. Dünser, MD (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +41 31 632 2111; Fax: +41 31 632 29644.

References 

  1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498–1504
  2. Guyton AC, Hall JE. Circulatory shock and physiology of its treatment. In:  Guyton AC,  Hall JE editor. Textbook of medical physiology. 10th edn.. Philadelphia: W.B. Saunders; 2000;p. 253–262
  3. Benedict CR, Grahame-Smith DG. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydoxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. The Quarterly Journal of Medicine. 1978;47:1–20
  4. Voelckel W, Wenzel V. Managing hemorrhagic shock: fluids on the way – drugs on the way in?. Critical Care Medicine. 2003;31:2552–2553
  5. Dolich M, Cohn S. Solutions for volume resuscitation in trauma patients. Current Opinion in Critical Care. 1999;5:523–528
  6. Cannon W, Fraser J, Cowell E. The preventative treatment of wound shock. JAMA: The Journal of the American Medical Association. 1918;70:618–621
  7. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. The New England Journal of Medicine. 1994;331:1105–1109
  8. Kwan I, Brunn F, Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database of Systematic Reviews (Online). 2003;CD002245
  9. Roberts I, Evans P, Bunn F, et al. Is the normalisation of blood pressure in bleeding trauma patients harmful?. Lancet. 2001;357:385–387
  10. Martinowitz U, Kenet G, Lubetski A, et al. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemrrhage associated with massive trauma. Canadian Journal of Anaesthesia. 2002;49:15–20
  11. Krismer AC, Wenzel V, Lindner KH, et al. Influence of negative expiratory pressure ventilation on hemodynamic variables during severe hemorrhagic shock. Critical Care Medicine. 2006;34:2175–2181
  12. Goodin TH, Grossbard EB, Kaufman RJ, et al. A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study. Critical Care Medicine. 1994;22:680–689
  13. Dunser MW, Lindner KH, Wenzel V. Vasopressin: multitalented hormone among the shock hormones?. Critical Care Medicine. 2006;34:562–564
  14. Szabo C, Salzman AL. Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock. 1996;5:391–394
  15. Safar PJ, Tisherman SA. Suspended animation for delayed resuscitation. Current Opinion in Anaesthesiology. 2002;15:203–210
  16. Nozari A, Safar P, Wu X, et al. Suspended animation can allow survival without brain damage after traumatic exsanguinations cardiac arrest of 60 minutes in dogs. The Journal of Trauma. 2004;57:1266–1275
  17. Lienhart HG, Wenzel V, Braun J, et al. Vasopressin for therapy of persistent traumatic hemorrhagic shock. The Vitris.at Study. Anaesthesist. 2007;56:145–150
  18. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. The New England Journal of Medicine. 2001;345:588–595
  19. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the last phase of hemorrhagic shock. Circulation. 1999;100:226–229
  20. Fries D, Streif W, Haas T, Kühbacher G. Dilutional coagulopathy, an underestimated problem?. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2004;39:745–750
  21. Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia. 2001;15:316–321
  22. Deusch F, Gamsjäger T, Kress HG, Kozek-Langenecker SA. Binding of hydroxyethyl starch molecules to the platelet surface. Anesthesia and Analgesia. 2003;97:680–683
  23. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1 – receptor physiology. Critical Care (London, England). 2003;7:427–434
  24. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 2 – clinical physiology. Critical Care (London, England). 2004;8:15–23
  25. Guyton AC, Hall JE. Hemostasis and blood coagulation. In:  Guyton AC,  Hall JE editor. Textbook of medical physiology. 10th edn.. Philadelphia: W.B. Saunders; 2000;p. 419–429
  26. Seamon MJ, Fisher CA, Gaughan J, et al. Prehospital procedures before emergency department thoracotomy: “scoop and run” saves lives. The Journal of Trauma. 2007;63:113–120
  27. Demetriades D, Martin M, Salim A, et al. The effect of trauma center designation and trauma volume on outcome in specific severe injuries. Annals of Surgery. 2005;242:512–517
  28. Demetriades D, Martin M, Salim A, et al. Relationship between American College of Surgeons trauma center designation and mortality in patients with severe trauma (injury severity score >15). Journal of the American College of Surgeons. 2006;202:212–215
  29. Ota K, Kimura T, Matsui K, et al. Effects of hemorrhage on vasopressin and Met-Enk release in blood and cerebrospinal fluid in dogs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 1988;255:731–736
  30. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Medicine. 2004;30:1276–1291
  31. Hock CE, Su JY, Lefer AM. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock. American Journal of Physiology. Heart and Circulatory Physiology. 1984;246:H174–H179
  32. Westermann I, Dunser MW, Haas T, et al. Endogenous vasopressin and copeptin response in multiple trauma patients. Shock. 2007;[epub ahead of print]
  33. Jochberger S, Mayr VD, Luckner G, et al. Serum vasopressin concentrations in critically ill patients. Critical Care Medicine. 2006;34:293–299
  34. Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Critical Care Medicine. 2003;31:1752–1758
  35. Voelckel W, Lurie KG, Lindner KH, et al. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesthesia and Analgesia. 2000;91:627–634
  36. Stadlbauer KH, Wagner-Berger HG, Raedler C, et al. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal and hemorrhagic shock in pigs. Anesthesiology. 2003;98:699–704
  37. Voelckel WG, Raedler C, Wenzel V, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Critical Care Medicine. 2003;31:1160–1165
  38. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesthesia and Analgesia. 2004;98:1759–1766
  39. Johnson KB, Pearce FJ, Jeffreys N, et al. Impact of vasopressin on hemodynamic and metabolic function in the decompensatory phase of hemorrhagic shock. Journal of Cardiothoracic and Vascular Anesthesia. 2006;20:167–172
  40. Yoo JH, Kim MS, Park HM. Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock. The Journal of Veterinary Medical Science. 2006;68:967–972
  41. Yoo JH, Kim MS, Eom KD, et al. Vasopressor therapy using vasopressin prior to crystalloid resuscitation in irreversible hemorrhagic shock under isoflurane anesthesia in dogs. The Journal of Veterinary Medical Science. 2007;69:459–464
  42. Cheung AT, To PL, Chan DM, et al. Comparison of treatment modalities for hemorrhagic shock. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 2007;35:173–190
  43. Driessen B, Zarucco L, Gunther RA, et al. Effects of low-volume haemoglobin glutamer-200 versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model. Critical Care Medicine. 2007;35:2221–2227
  44. Cohn SM. Potential benefit of vasopressin in resuscitation of hemorrhagic shock. The Journal of Trauma. 2007;68:56–57
  45. Goff JS. Gastroesophageal varices: pathogenesis and therapy of acute bleeding. Gastroenterology Clinics of North America. 1993;22:779–800
  46. Haas T, Voelckel W, Wiedermann F, et al. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. The Journal of Trauma. 2004;57:177–179
  47. Krismer AC, Wenzel V, Voelckel WG, et al. Applying vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature. Der Anaesthesist. 2005;54:220–224
  48. Sharma RM, Setlur R. Vasopressin in hemorrhagic shock. Anesthesia and Analgesia. 2005;101:833–834
  49. Yeh CC, Wu CT, Lu CH, et al. Early use of small-dose vasopressin for unstable hemodynamics in an acute brain injury patient refractory to catecholamine treatment: a case report. Anesthesia and Analgesia. 2003;97:577–579
  50. Meyer S, Gottschling S, Gortner L. The use of terlipressin in a 14-year old adolescent with catecholamine-resistant shock after severe traumatic brain injury. Acta Anaesthesiologica Scandinavica. 2007;51:957
  51. Salluh JI, Martins GA, Santino MS, et al. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury. Acta Anaesthesiologica Scandinavica. 2007;51:505–508
  52. Feinstein AJ, Patel MB, Sanui M, et al. Resuscitation with pressors after traumatic brain injury. Journal of the American College of Surgeons. 2005;201:536–545
  53. Sanui M, King DR, Feinstein AJ, et al. Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury. Critical Care Medicine. 2006;34:433–438
  54. Meybohm P, Cavus E, Bein B, et al. Small volume resuscitation: a randomized controlled trial with either norepinephrine or vasopressin during severe hemorrhage. The Journal of Trauma. 2007;62:640–646
  55. Meybohm P, Cavus E, Dorges V, et al. Release of protein S100B in haemorrhagic shock: effects of small volume resuscitation combined with arginine vasopressin. Resuscitation. 2007;[epub ahead of print]
  56. Back SM, Kim SS. Successful digital replantation after 42 hours of warm ischemia. Journal of Reconstructive Microsurgery. 1992;8:455–458
  57. Nissenson AR. Acute renal failure: definition and pathogenesis. Kidney International. Supplement. 1998;66:S7–S10
  58. Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis – Clinical and hemodynamic study in 142 consecutive cases. Medicine. 2003;82:392–406
  59. Lock G, Schölmerich J. Non-occlusive mesenteric ischemia. Hepato-gastroenterology. 1995;42:234–239
  60. Deitch EA, Dayal SD. Intensive care unit management of the trauma patient. Critical Care Medicine. 2006;34:2294–2301
  61. Elster E. Trauma and the immune response: strategies for success. The Journal of Trauma. 2007;62:S54–S55
  62. Shelly MP, Greatorex R, Calme RY, Park GR. The physiological effects of vasopressin when used to control intra-abdominal bleeding. Intensive Care Medicine. 1988;14:526–531
  63. Mayr VD, Wenzel V, Müller T, et al. Effects of vasopressin on left anterior descending coronary artery blood flow during extremely low cardiac output. Resuscitation. 2004;62:229–235
  64. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. The New England Journal of Medicine. 2004;350:105–113
  65. Luckner G, Dünser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Critical Care Medicine. 2005;33:2659–2666

 Supported in part by the Science Foundation of the Austrian National Bank grant 11448, Vienna, Austria.

PII: S1521-6896(08)00005-0

doi: 10.1016/j.bpa.2008.02.003

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 299-316 , June 2008